CAM
MDCO

Capstone Asset Management’s Medicines Co MDCO Stock Holding History

Capstone Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$526K Sell
13,849
-1,210
-8% -$53.9K 0.01% 885
2017
Q1 		$736K Sell
15,059
-2,040
-12% -$93K 0.02% 699
2016
Q4 		$580K Sell
17,099
-4,230
-20% -$150K 0.02% 836
2016
Q3 		$805K Sell
21,329
-370
-2% -$13.9K 0.02% 676
2016
Q2 		$730K Buy
21,699
+940
+5% +$33.1K 0.02% 708
2016
Q1 		$660K Sell
20,759
-1,070
-5% -$34.9K 0.02% 753
2015
Q4 		$815K Buy
21,829
+1,340
+7% +$50.6K 0.02% 668
2015
Q3 		$778K Buy
20,489
+1,150
+6% +$40.4K 0.02% 646
2015
Q2 		$553K Sell
19,339
-10,040
-34% -$280K 0.02% 900
2015
Q1 		$823K Buy
29,379
+620
+2% +$17.4K 0.02% 763
2014
Q4 		$796K Sell
28,759
-9,160
-24% -$227K 0.02% 758
2014
Q3 		$846K Buy
37,919
+100
+0.3% +$2.54K 0.03% 666
2014
Q2 		$1.1M Buy
37,819
+4,217
+13% +$113K 0.04% 574
2014
Q1 		$955K Sell
33,602
-260
-0.8% -$8.6K 0.03% 638
2013
Q4 		$1.31M Sell
33,862
-3,681
-10% -$132K 0.04% 530
2013
Q3 		$1.26M Buy
37,543
+3,530
+10% +$112K 0.03% 644
2013
Q2 		$1.05M Buy
+34,013
New +$1.14M 0.03% 679

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capstone Asset Management's MDCO Position: Q2 2017 in Review

Capstone Asset Management reduced its Medicines Co (MDCO) stake by 8% in Q2 2017, selling an estimated $53.9K and leaving 13,849 shares worth $526K. The position accounts for 0.01% of the portfolio, ranked #885.

Capstone Asset Management first reported a position in MDCO in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.31M in Q4 2013. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

  • Capstone Asset Management held 13,849 shares of Medicines Co worth $526K as of Q2 2017.
  • Capstone Asset Management sold 1,210 Medicines Co shares in Q2 2017, an estimated $53.9K.
  • Medicines Co made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #885 holding.
  • Capstone Asset Management first reported a position in Medicines Co in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Medicines Co position peaked at $1.31M in Q4 2013.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.